Development and validation of a competing risk model for second primary pancreatic ductal adenocarcinoma: A population-based study

BACKGROUND: With advances in early diagnosis and treatment, the number of cancer survivors continues to grow, and more and more cancer survivors face the threat of second primary cancer (SPM). Second primary pancreatic ductal adenocarcinoma (spPDAC) is an important subclass of SPM, but its prognosti...

Descripción completa

Detalles Bibliográficos
Autores principales: Song, Lishan, Xu, Chaojie, Zhang, Tong, Chen, Shengyang, Shi, Zhigang, Hu, Shuiquan, Cheng, Bingbing, Tong, Hao, Wei, Guangkun, Li, Xiaoyong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Surgery
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9468218/
https://www.ncbi.nlm.nih.gov/pubmed/36111234
http://dx.doi.org/10.3389/fsurg.2022.934148

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9468218/
https://www.ncbi.nlm.nih.gov/pubmed/36111234
http://dx.doi.org/10.3389/fsurg.2022.934148

Ejemplares similares